Online Media Kit


March 16, 2022 | Times LIVE (South Africa)

The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women.


February 26, 2022 | The East African (Kenya)

Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring.


January 26, 2021 | World Health Organization

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as...

Media Highlights

July 28, 2021 | Aidsmap (UK)

Encouragingly, adherence to the monthly dapivirine ring and daily oral PrEP was higher in the REACH study than rates seen in prior trials. In the DELIVER study, adverse pregnancy outcomes and...

July 20, 2021 | MedPage Today

The long-acting dapivirine vaginal ring, which reduces HIV risk in young women, had a comparable safety profile in late pregnancy to an oral daily PrEP regimen, according to an interim analysis of a...

July 14, 2021 | HealthTimes (Zimbabwe)

Zimbabwe becomes one of the first countries in Africa and the region to have approved use of the Dapivirine Ring, a flexible silicone ring that a woman can insert in the vagina for monthly protection...

March 09, 2021 | Gizmodo

New research suggests that people can wear a dapivirine vaginal ring meant to prevent HIV infection for as long as three months. 

March 09, 2021 | HealthDay

Results from a Phase I trial reported at CROI 2021 found encouraging drug levels with use of a 90-day dapivirine ring, with no safety concerns.